44.83
Artivion Inc (AORT) 最新ニュース
Artivion Inc. Inches Above Key Support — Safe to HoldRate Cut & Short-Term Trading Alerts - thegnnews.com
Artivion's Insider Transactions: A Governance and Liquidity Lens into Q2 2025 Performance - AInvest
Artivion CEO Mackin sells $528k in shares - Investing.com
Artivion price target raised to $41 from $35 at Canaccord - MSN
Artivion Inc. Building a Base Near SupportWeekly Investment Summary & AI Powered Market Trend Analysis - beatles.ru
Price Floor Holding on Artivion Inc. — Rebound PossibleWeekly Profit Recap & Community Verified Trade Signals - metrotimes.co.kr
Can Artivion Inc. ride the EV wave2025 Volume Leaders & Free Expert Verified Stock Movement Alerts - newsyoung.net
Is Artivion Inc. stock heavily shortedJuly 2025 News Drivers & Real-Time Volume Trigger Notifications - newsyoung.net
Reversal Confirmed Artivion Inc. Stock Rallies Above MAJuly 2025 Short Interest & Daily Profit Maximizing Tips - newsimpact.co.kr
Artivion's Strong Financials and Promising Pipeline Justify Buy Rating - AInvest
Real Time Chart Alerts Flash Bullish on Artivion Inc.Forecast Cut & Safe Capital Growth Tips - sundaytimes.kr
Artivion Inc. Attempts Reversal From Key SupportGDP Growth & AI Driven Price Predictions - classian.co.kr
Artivion SVP Holloway sells $1m in shares after option exercise - Investing.com
Artivion’s chief commercial officer Davis sells $471k in shares - Investing.com
Artivion’s chief commercial officer Davis sells $471k in shares By Investing.com - Investing.com UK
Artivion Insider Sold Shares Worth $471,756, According to a Recent SEC Filing - MarketScreener
Chart based analysis of Artivion Inc. trends2025 Institutional Moves & Growth Focused Investment Plans - Newser
Earnings visualization tools for Artivion Inc.Weekly Volume Report & AI Driven Price Forecasts - Newser
Will Artivion Inc. stock benefit from interest rate changesPortfolio Value Summary & Daily Volume Surge Signals - Newser
Artivion stock hits 52-week high at 43.93 USD - Investing.com
Artivion stock hits 52-week high at 43.93 USD By Investing.com - Investing.com Canada
Artivion at Canaccord Conference: Strategic Growth and Innovation - Investing.com
Artivion at Canaccord Conference: Strategic Growth and Innovation By Investing.com - Investing.com Nigeria
Is this a good reentry point in Artivion Inc.July 2025 Action & Daily Growth Stock Investment Tips - Newser
Artivion, Inc. (NYSE:AORT) Stock Holdings Lifted by Natixis Advisors LLC - Defense World
Artivion's (AORT) Buy Rating Reiterated at Needham & Company LLC - MarketBeat
Is now a turning point for Artivion Inc.IPO Watch & AI Driven Stock Reports - Newser
Revenues Tell The Story For Artivion, Inc. (NYSE:AORT) As Its Stock Soars 37% - simplywall.st
Artivion, Inc. (NYSE:AORT) Q2 2025 Earnings Call Transcript - Insider Monkey
Technical signs of recovery in Artivion Inc.Reversal Signal Prediction Based on Volume - Newser
Artivion Inc. Reports Strong Q2 Earnings and Positive Outlook - TipRanks
Artivion Appoints Lance Berry as COO, Raises Earnings Guidance - AInvest
Artivion Appoints Lance Berry as COO - MarketScreener
Artivion Appoints Lance A. Berry as COO - TipRanks
Artivion Reaches Analyst Target Price - Nasdaq
Artivion Surges on Improved 2025 Financial Outlook - StocksToTrade
Artivion’s Stocks Surge as Q2 Financials Exceed Expectations - timothysykes.com
Artivion (NYSE:AORT) Earns “Buy” Rating from Needham & Company LLC - Defense World
Canaccord Genuity Group Forecasts Strong Price Appreciation for Artivion (NYSE:AORT) Stock - Defense World
What technical models suggest about Artivion Inc.’s comebackPredictive Short-Term Market Reversal Alerts - Newser
Artivion raises 2025 revenue guidance to $435M–$443M as On-X and stent grafts drive double-digit growth - MSN
Artivion's Q2 Earnings Surge: A High-Margin Medical Innovation Play with Undervalued Potential - AInvest
Artivion, Inc.'s (NYSE:AORT) 26% Jump Shows Its Popularity With Investors - 富途牛牛
Artivion price target raised to $45 from $32 at Needham - Yahoo Finance
Artivion Second Quarter 2025 Earnings: Beats Expectations - uk.finance.yahoo.com
Artivion Elevates 2025 Revenue Projection Amid Strong Q2 Earnings - StocksToTrade
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $40 to $45 - 富途牛牛
Artivion 2025 Q2 Earnings Strong Performance with Net Income Surges 163% - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Artivion (NYSE:AORT) Shares Gap Up on Better-Than-Expected Earnings - Defense World
Artivion (NYSE:AORT) Stock Rating Upgraded by Wall Street Zen - Defense World
Comparing Artivion Inc. in custom built stock radarsSector-Wise Equity Performance Trend Forecast - Newser
Artivion Inc. stock trend forecastFree Swing Trading Entry Point Signals - Newser
Artivion (AORT): Canaccord Genuity Raises Price Target to $41.00 - GuruFocus
Artivion: Canaccord Genuity Raises PT to $41 from $35, Maintains Buy Rating - AInvest
Artivion’s Surging Stock: Rising Star or Temporary Miracle? - timothysykes.com
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $35 to $45 - 富途牛牛
Artivion (AORT): Accelerating Growth and Margin Expansion in a High-Margin Medical Device Niche - AInvest
Artivion Raises 2025 Revenue Guidance to $435M-$443M, Driven by On-X and Stent Grafts. - AInvest
大文字化:
|
ボリューム (24 時間):